Earnings Preview For Voyager Therapeutics
Portfolio Pulse from Benzinga Insights
Voyager Therapeutics (NASDAQ:VYGR) is scheduled to release its quarterly earnings report on February 28, 2024, with an estimated EPS of $-0.29. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions to past earnings, with the stock price fluctuating based on the actual EPS compared to estimates. Shares have risen 22.39% over the last 52 weeks, indicating a generally positive outlook from long-term shareholders.
February 27, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Voyager Therapeutics is expected to report an EPS of $-0.29 for the latest quarter. Historical performance shows stock price reactions to earnings outcomes and guidance. Shares have increased by 22.39% over the past year.
The short-term impact on VYGR's stock price will likely depend on whether the company beats the EPS estimate and provides positive future guidance. Historical data indicates that the stock price can react positively or negatively to earnings outcomes. Given the 22.39% increase over the past year, investor sentiment appears positive, but the immediate reaction will hinge on the earnings report details.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100